Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Super Group (SGHC) Limited Ordinary Shares (SGHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Super Group (SGHC) Limited Ordinary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Super Group (SGHC) Limited Ordinary Shares trades at $11.29 (market cap $5.86B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 2.1× Super Group (SGHC) Limited Ordinary Shares's market cap, and Super Group (SGHC) Limited Ordinary Shares pays a 1.73% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Super Group (SGHC) Limited Ordinary Shares for 1 Days on average.
| HALO | SGHC | |
|---|---|---|
Market Cap | $12.58B | $5.86B |
Volume | 2,179,278 | 1,905,788 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $15.59 |
52-Week Low | $61.63 | $8.52 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $5.41B |
Dividend Yield | — | 1.73% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Super Group (SGHC) Limited Ordinary Shares
Super Group (SGHC) Limited is a holding company for online sports betting and gaming businesses, operating the Betway sports betting brand and the Spin multi-brand online casino portfolio across markets in Europe, the Americas, and Africa.
Read more on SGHC →
